22nd Bangkok International Symposium on HIV Medicine 2020
Welcome to 22nd Bangkok International Symposium on HIV Medicine 2020
Organized by HIV-NAT

Program

Download Program  Latest updated on: January 8, 2020

  • Lectures

    • Memorial Lecture of Prof. David Cooper: Future Directions for HIV therapies
    • Memorial Lecture of Prof. Joep Lange and Ms. Jacqueline van Tongeren: Access, IP and human rights
    • PrEP Roundtable and Panel Discussion
    • JIAS Workshop: How to write and submit a research manuscript
    • TB and HBV
    • HIV Prevention and Care
    • New Technologies in Testing, Prevention and Treatment
    • Young Investigator Oral Plenaries
  • Workshop

    • Comorbidities and Toxicities workshop
    • Paediatric workshop
    • Transgender Health in HIV Primary Care Settings workshop
    • TB Workshop - Treatment and Prevention
    • Adolescent Workshop
    • Laboratory Workshop
  • WEDNESDAY JANUARY 15 (07.30-18.00 hr)
    • 07.30-08.45 hr
      Open check-in & Registration
    • 08.45-09.00 hr
      Opening Ceremony
      Tej Bunnag, PhD
    • Memorial Lectures And Plenaries (GH 202-203)
      Chairperson:
      Denise Hsu, BSc, MBBS, PhD
    • 09.00-09.30 hr
      Prof. David Cooper Memorial Lecture: Future Directions for HIV therapies
      Anthony Kelleher, MBBS, PhD, FRACP, FRCPA
        
    • 09.30-10.00 hr
      Prof. Joep Lange and Ms. Jacqueline van Tongeren Memorial Lecture: Treatment for all means getting treatment to all: Where are we now in the Asia-Pacific?
      Giten Khwairakpam, MSW
        
    • 10.00-10.30 hr
      Update on New ARTs
      Daniel Kuritzkes, MD
        
    • 10.30-11.00 hr
      Coffee and Poster Viewing
    • DAY 1 Interviewing Session 1
    • PrEP Roundtable (GH 202-203)
      Chairperson:
      Nittaya Phanuphak, MD, PhD
    • 11.00-11.20 hr
      Overview of PrEP implementation models
      Toshibumi Taniguchi, MD, PhD
        
    • 11.20-11.30 hr
      Thailand’s road to universal coverage of PrEP
      Taweesap Siraprapasiri, MD, MPH
        
    • 11.30-11.50 hr
      TRC experience with PrEP
      Reshmie Ramautarsing, MD, PhD
        
    • 11.50-12.10 hr
      The Perils of PrEP - STI and Resistance
      Donn J Colby, MD, MPH
        
    • 12.10-12.30 hr
      Panel Discussion Facilitated
      • Nittaya Phanuphak, MD, PhD
      • Toshibumi Taniguchi, MD, PhD
      • Taweesap Siraprapasiri, MD, MPH
      • Reshmie Ramautarsing, MD, PhD
      • Donn J Colby, MD, MPH
    • 12.30-14.00 hr
      Satellite Lunch Symposium by Gilead
    • DAY 1 Interviewing session 2
    • 14.00-16.00 hr
      WORKSHOP DAY 1
    • 16.00-18.00 hr
      Poster Viewing (MR 211-212)
  • THURSDAY JANUARY 16 (07.45-16.30 hr)
    • JIAS Workshop (MR 222-223)
    • 07.45-08.45 hr
      How to write and submit a research manuscript
      Annette Sohn, MD
      Not allow to distribute video
    • TB and HBV (GH 202-203)
      Chairperson:
      Sivaporn Gatechompol, MD
    • 09.00-09.30 hr
      Novel TB diagnosis and biomarkers
      Frank Cobelens, MD, PhD
        
    • 09.30-10.00 hr
      Update on TB treatment and challenges
      Richard Chaisson
        
    • 10.00-10.30 hr
      Hepatitis B Cure
      Sharon Lewin, FRACP, PhD, FAAHMS
        
    • 10.30-11.00 hr
      Coffee and Poster Viewing
    • Day 2 Interviewing session 1
    • Prevention and Care (GH 202-203)
      Chairperson:
      Tanat Chinbunchorn, MD
    • 11.00-11.30 hr
      Ending the Epidemic: Through Prevention in Priority Youth Populations
      Renata Sanders, MD, MPH, ScM
        
    • 11.30-12.00 hr
      Effective responses and harm reduction for problematic chemsex
      Matthew Mimiaga, ScD, MPH
        
    • 12.00-12.30 hr
      Mental health in PLWH
      Paul Thisayakorn, MD
      Not allow to distribute slide presentation and video
    • 12.30-14.00 hr Lunchtime Seminar
      Horizons in HIV Management: Looking back and moving forward
      Charles B. Hicks, MD
        
    • Day 2 Interviewing session 2
    • 14.00-16.30 hr
      WORKSHOP DAY 2
  • FRIDAY JANUARY 17 (09.00-15.00 hr)
    • New Technologies in Testing, Prevention and Treatment (GH 202-203)
      Chairperson:
      Eugene Kroon, MD
    • 09.00-09.30 hr
      BNABs
      Denise Hsu, BSc, MBBS, PhD
        
    • 09.30-10.00 hr
      The art of initiating ART
      Iskandar Azwa, MD
        
    • 10.00-10.30 hr
      The art of managing HIV resistance
      Daniel Kuritzkes, MD
        
    • 10.30-11.00 hr
      Coffee Break
    • Day 3 Interviewing session 1
    • 11.00-12.00 hr
      Young Investigator Oral Plenaries (GH 202-203)
      Chairperson:
      Thanyawee Puthanakit, MD
      Prevalence and patterns of HIV testing among MSM in Hanoi
      Bui Thi Minh Hao, MD
        
      Reaching the third 95: Increasing viral suppression rates among people living with HIV in Cambodia
      Sodara Chan, MD
        
      Not allow to distribute video
      Successful discontinuation of itraconazole for secondary prophylaxis of Talaromycosis in patients with HIV in Myanmar
      Ni Ni Tun, MD
        
      Evaluation of AFB and Xpert MTB/RIF for diagnosis of tuberculosis in Yogyakarta, Indonesia
      Titik Nuryastuti, MD, MSc, PhD
        
    • 12.00-13.30 hr Lunchtime Seminar
      Update of rapid anti-HIV tests including HIV self-tests (both WHO prequalified and those in the markets)
      Tan Swee Jin, MD, PhD
        
      Update of qualitative and quantitative molecular HIV tests including point-of-care tests
      Eugene Neo, PhD
        
      Update of HIV genotypic resistance testing including next gen. sequencing assay
      Daniel Kuritzkes, MD
        
    • Day 3 Interviewing session 2
    • Afternoon Plennaries (GH 202-203)
      Chairperson:
      Stephen Kerr, PhD
    • 13.30-14.00 hr
      HIV therapy in an era of polypharmacy
      Tim Cressey, PhD
        
    • 14.00-14.30 hr
      Update on STI management
      Donn J Colby, MD, MPH
        
    • 14.30-15.00 hr
      Healthy aging in PLWH
      Reena Rajasuriar, MPHARM, PhD
        
    • 15.00 hr
      Closure of the Conference

WORKSHOP DAY 1 (14.00-16.00 hr)

  • Comorbidities and Toxicities (GH 202-203)
    Interactive e-voting
    Chairpersons:
    Peter Reiss, MD, PhD
    Chureeratana Bowonwatanuwong, MD
    • Vaccination in HIV infected individuals
      Sasisopin Kiertiburanakul, MD, MHS
        
    • Kidney complications isn PLWH
      Suwasin Udomkarnjananun, MD, MSc
        
    • Neurosyphilis
      Phillip Chan
        
    • Metabolic changes
      Thornthun Ueaphongsukkit, MD
        
  • Paediatric workshop (GH 201)
    Interactive e-voting
    Chairperson:
    Suvaporn Anugulruengkitt, MD, PhD
    • New antiretroviral treatment for pediatric and adolescent living with HIV
      Kulkanya Chokephaibulkit, MD
        
    • Challenges in tuberculosis management in pediatric HIV
      Watsamon Jantarabenjakul, MD
        
    • Bone and metabolic complications among HIV-infected youth
      Tavitiya Sudjaritruk, MD, PhD
        
    • Challenges for Transition to Adult-HIV treatment service
      Thanyawee Puthanakit, MD
        
  • Transgender Health in HIV Primary Care Settings (MR 222-223)
    Chairperson:
    Rena Janamnuaysook, MBA
    • Management of gender-affirming hormone treatment for transgender women
      Tanat Chinbunchorn, MD
        
    • Post-operative care and neovagina care
      Worapon Ratanalert, MD
        
    • Mental health and psychosocial support among transgender people
      Elizabeth Ceissman
        
    • Community perspectives on transgender health in HIV primary care settings
      Nisha Ayub
        

WORKSHOP DAY 2 (14.00-16.30 hr)

  • TB Workshop - Treatment and Prevention (GH 202-203)
    Interactive e-voting
    Chairpersons:
    Sivaporn Gatechompol, MD
    Anchalee Avihingsanon, MD, PhD
    • Managing drug interactions in the treatment of tuberculosis
      Anchalee Avihingsanon, MD, PhD
        
    • Deciding When and how to Treat Latent TB Infection
      Richard Chaisson
      Not allow to distribute slide presentation and video
    • Challenges in detection and treatment of multidrug resistant TB
      Charoen Chuchottaworn, MD
        
    • Updating management for preventing and treating cryptococcal disease
      Ploenchan Chetchotisakd, MD
        
  • Adolescent Workshop (GH 201)
    Interactive e-voting
    Chairpersons:
    Chitsanu Pancharoen, MD
    • PrEP and comprehensive service delivery among transgender adolescent in United States
      Renata Sanders, MD, MPH, ScM
        
    • Adolescent focus HIV-prevention services in Thailand
      Wipaporn Natalie Songtaweesin, MD
        
    • HIV prevention program for adolescent in Asia Pacific - CDC perspectives
      Eileen F Dunne, MD
        
    • Interplay between substance abuse and HIV in adolescent
      Apinun Aramrattana, MD, PhD
        
  • Laboratory Workshop: Supporting End TB: Update diagnostics for latent tuberculosis infection (LTBI) (MR 222-223)
    Chairpersons:
    Apicha Mahanontharit
    • 14.00-14.15 hr
      Latent TB diagnosis: Immunodiagnosis
      Sasiwimol Ubolyam, PhD, MSc
        
    • 14.15-14.45 hr
      The CD25/CD134 (OX40) assay: Role of latent TB diagnosis
      Anthony Kelleher, MBBS, PhD, FRACP, FRCPA
        
    • 14.45-15.00 hr
      Afternoon Coffee Break
    • 15.00-15.45 hr
      New technology for unmasking latent TB infection
      Masae Kawamura, MD
        
    • Q&A and discussion
    • Q&A by Facilitators
      • Sasiwimol Ubolyam, PhD, MSc
      • Apicha Mahanontharit